Linda Dear: Menodoctor Clinical Director on Pharmac's new measures to address HRT patch shortage
Heather du Plessis-Allan Drive · Newstalk ZB
Audio is streamed directly from the publisher (pdst.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Increased restrictions for HRT menopause treatment, as Pharmac finds ways shore up supply of oestradiol patches.
It's changing its main funded brand to Estradiol TDP Mylan from supplier Viatris from next July.
In order to ensure supply, it'll be the only funded brand available by December 2025.
Menodoctor Clinical Director, Linda Dear, says those who can't use the Mylan brand will have other options.
"Most women who get on with other, non-Mylan brands will get on with gel fine - but it means they'll have to start probably thinking about that transition."
LISTEN ABOVE
See omnystudio.com/listener for privacy information.